Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.
Bu Y, Cai G, Shen Y, Huang C, Zeng X, Cao Y, Cai C, Wang Y, Huang D, Liao DF, Cao D.
Bu Y, et al. Among authors: wang y.
Cancer Lett. 2016 Dec 28;383(2):261-271. doi: 10.1016/j.canlet.2016.10.006. Epub 2016 Oct 6.
Cancer Lett. 2016.
PMID: 27721021